Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-197.56%Return on Assets
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Return on Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - ROA Historical data
| Date | Total Assets | Net Income Common Stock | Return on Assets |
|---|---|---|---|
| 6/30/2025 | $ 25.79M | $ -50.95M | -197.56% |
| 3/31/2025 | $ 38.57M | $ -40.06M | -103.88% |
| 12/31/2024 | $ 38.34M | $ -59.6M | -155.46% |
| 9/30/2024 | $ 48.89M | $ -71M | -145.21% |
| 6/30/2024 | $ 65.44M | $ -107.83M | -164.79% |
| 3/31/2024 | $ 82.32M | $ -153.05M | -185.91% |
| 12/31/2023 | $ 73.7M | $ -179.05M | -242.94% |
| 9/30/2023 | $ 100.45M | $ -211.6M | -210.66% |
| 6/30/2023 | $ 140.1M | $ -202.92M | -144.85% |
| 3/31/2023 | $ 180.1M | $ -187.08M | -103.87% |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) ROA stands at -29.05%.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average ROA has been -106.31%.
- The median ROA for BIOXCEL THERAPEUTICS INC during this period was -92.2%
- BIOXCEL THERAPEUTICS INC reached its highest ROA over the past 5 years at -29.05%.
- The lowest ROA recorded by BIOXCEL THERAPEUTICS INC in the same timeframe -242.94%
BIOXCEL THERAPEUTICS INC's ROA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROA Benchmarks
Similar metrics to ROA:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Equity - [Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Definition of Return on Assets
[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.Net Inc. Cmn. / Assets
(=) ROA ROA for BIOXCEL THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -69.36M ] / Assets [ $ 238.75M ]
(=) ROA [ -29.05% ] BTAI - Return on Assets, Last 5 years
-242.94%
Minimum
Dec 31, 2023
-29.05%
Maximum
Sep 30, 2020
-106.31%
Average
-92.2%
Median
ROA Benchmark AnalysisMarket
The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.12% with a standard deviation of 10.61%.
The following table provides additional summary stats:
ROA in the Market:
| filtered constituents | 3.44K |
|---|---|
| min | -33.4% |
| max | 33.98% |
| average | 0.12% |
| median | 1.53% |
| std | 10.61% |